Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for ImmunoBrain Checkpoint

    Client Virtual Booth

    IMMUNOBRAIN CHECKPOINT

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ImmunoBrain Checkpoint
    Israel Flag
    Country
    Country
    Israel
    Address
    Address
    Weizmann Science Park 3 Pinhas Sapir street, Ness Ziona, IL
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ibcheckpoint.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ImmunoBrain Checkpoint Appoints Dr. Sanjay Keswani as Chief Executive Officer
    ImmunoBrain Checkpoint Appoints Dr. Sanjay Keswani as Chief Executive Officer

    https://www.prnewswire.com/news-releases/immunobrain-checkpoint-appoints-dr-sanjay-keswani-as-chief-executive-officer-302039635.html

    PR NEWSWIRE
    22 Jan 2024
    Share Share
    First subjects in IBC’s Phase Ib trial receive IBC-Ab002
    First subjects in IBC’s Phase Ib trial receive IBC-Ab002

    https://www.clinicaltrialsarena.com/news/first-subjects-ibcs-trial-ibc-ab002/

    CLINICAL TRIALS ARENA
    18 May 2023
    Share Share
    ImmunoBrain Checkpoint Doses First Patients in Phase 1b Trial of IBC-Ab002
    ImmunoBrain Checkpoint Doses First Patients in Phase 1b Trial of IBC-Ab002

    https://www.prnewswire.com/news-releases/immunobrain-checkpoint-doses-first-patients-in-phase-1b-clinical-trial-of-ibc-ab002-for-alzheimers-disease-301826238.html

    PR NEWSWIRE
    17 May 2023
    Share Share
    ImmunoBrain Awarded $5M for Phase 1b Alzheimer’s Disease of Anti-PD-L1 IBC-Ab002
    ImmunoBrain Awarded $5M for Phase 1b Alzheimer’s Disease of Anti-PD-L1 IBC-Ab002

    https://www.globenewswire.com/news-release/2021/08/27/2287643/0/en/ImmunoBrain-Checkpoint-Awarded-5-Million-US-NIA-Grant-for-Phase-1b-Alzheimer-s-Disease-Proof-of-Mechanism-Study-of-Anti-PD-L1-IBC-Ab002.html

    GLOBENEWSWIRE
    27 Aug 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search